Goin Kathleeninsider trades
In SEC Form 4 filings, Goin Kathleen is listed as Chief Operating Officer of Palvella Therapeutics, Inc. (PVLA). In the last 90 days, Goin Kathleen sold $1.19M of Palvella Therapeutics, Inc. (PVLA) on the open market and bought none. All 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Chief Operating Officer | 14 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-18
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | M | 2,165 | $7.14 | $15,458 | 2,165 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | M | 2,148 | $9.08 | $19,504 | 4,313 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | S | 2,043 | $123.62 | Sale −$252,559 | 2,270 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | S | 1,663 | $125.16 | Sale −$208,149 | 607 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | S | 607 | $126.19 | Sale −$76,600 | not reported | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | M · derivative | 2,165 | $7.14 | $15,458 | not reported | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Oct 21 | Oct 23 | M · derivative | 2,148 | $9.08 | $19,504 | not reported | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | M | 2,154 | $7.14 | $15,380 | 2,154 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | M | 2,148 | $9.08 | $19,504 | 4,302 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | S | 1,659 | $151.16 | Sale −$250,773 | 2,643 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | S | 989 | $152.36 | Sale −$150,686 | 1,654 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | S | 1,654 | $153.24 | Sale −$253,465 | not reported | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | M · derivative | 2,154 | $7.14 | $15,380 | 2,165 | Yes | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 16 | Sep 18 | M · derivative | 2,148 | $9.08 | $19,504 | 2,148 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.